A comparison study of orviglance versus the gadolinium contrast agent for detection of liver disorder
Latest Information Update: 22 Dec 2021
At a glance
- Drugs CMC 001 (Primary) ; Gadobenic acid
- Indications Liver disorders
- Focus Diagnostic use
- 22 Dec 2021 New trial record
- 01 Dec 2021 According to an Ascelia Pharma Media Release, data form this trial presented at the Radiological Society of North America's radiology conference, RSNA, 2021.
- 01 Dec 2021 Results published in the Ascelia Pharma Media Release.